Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2015-03-06
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients
NCT02213016
Assessing the Stability of Transcranial Magnetic Stimulation Plasticity Responses
NCT03034629
Mechanism of Action of Transcranial Magnetic Stimulation
NCT04278521
Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes
NCT03289923
rTMS and Cognitive Training in Youth Depression
NCT03708172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TMS and Lumosity® cognitive retraining
Group will receive TMS and will concurrently engage in cognitive retraining exercises comprised of the Lumosity® battery.
TMS and Lumosity®cognitive retraining
The Lumosity® training includes exercises for speed, memory, attention, flexibility, and problem solving. Subjects will complete this battery while receiving TMS treatment.
TMS and non cognitive computer games
Group will receive TMS while concurrently engaging in selected computer games from several gaming software that includes Play 101 Games and Hoyle Puzzle and Board Games®. They will also be allowed to spend time on gaming activities of their choice in order to keep them engaged
TMS and non cognitive computer games
Subjects will play computer games while receiving TMS treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TMS and Lumosity®cognitive retraining
The Lumosity® training includes exercises for speed, memory, attention, flexibility, and problem solving. Subjects will complete this battery while receiving TMS treatment.
TMS and non cognitive computer games
Subjects will play computer games while receiving TMS treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has been approved and scheduled to receive TMS at Augusta University
* Subject does not have a major neurocognitive impairment or an alcohol or substance abuse disorder, and can see images on a computer monitor.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lumos Labs, Inc.
INDUSTRY
Augusta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Rosenquist
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter B Rosenquist, MD
Role: PRINCIPAL_INVESTIGATOR
Augusta University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Augusta University
Augusta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
663245
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.